Headquarters
107 GILBRETH PKWY, MULLICA HILL, NJ 08062-4446, US
MULLICA HILL, NJ, US
ENALARE THERAPEUTICS INC
From the company
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel therapies for life-threatening acute respiratory and critical care conditions. Its lead drug candidate, ENA-001, is a patent-protected new chemical entity with a novel mechanism of action, beginning additional clinical trials in the fourth quarter of 2021, targeting conditions such as drug overdose respiratory depression and apnea of prematurity. The company is located in Rowan University's Samuel H. Jones Innovation Center in Mullica Hill, NJ.
Products & services offered
Capabilities 2
Facilities
Send your requirements
Quantities, certifications, and timing.